Search by Drug Name or NDC

NDC 68071-1793-01 Enalapril Maleate 10 mg/1 Details

Enalapril Maleate 10 mg/1

Enalapril Maleate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NuCare Pharmaceuticals,Inc.. The primary component is ENALAPRIL MALEATE.

MedlinePlus Drug Summary

Enalapril is used alone or in combination with other medications to treat high blood pressure. It is also used in combination with other medications to treat heart failure. Enalapril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 68071-1793-01
Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Enalapril

Product Information

NDC	68071-1793
Product ID	68071-1793_fd0139df-1242-59b3-e053-6394a90a1375
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Enalapril Maleate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Enalapril Maleate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	10
Active Ingredient Units	mg/1
Substance Name	ENALAPRIL MALEATE
Labeler Name	NuCare Pharmaceuticals,Inc.
Pharmaceutical Class	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA213273
Listing Certified Through	2024-12-31

Package

NDC 68071-1793-01 (68071179301)

Pricing Information	N/A
NDC Package Code	68071-1793-1
Billing NDC	68071179301
Package	100 TABLET in 1 BOTTLE (68071-1793-1)
Marketing Start Date	2023-05-31
NDC Exclude Flag	N